{"id":"NCT01205438","sponsor":"Eli Lilly and Company","briefTitle":"A Study of LY2127399 in Participants With Systemic Lupus Erythematosus","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients With Systemic Lupus Erythematosus (SLE)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-01","primaryCompletion":"2014-08","completion":"2015-03","firstPosted":"2010-09-20","resultsPosted":"2018-06-19","lastUpdate":"2018-07-17"},"enrollment":1124,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Systemic Lupus Erythematosus","Connective Tissue Disease","Autoimmune Disease"],"interventions":[{"type":"DRUG","name":"LY2127399","otherNames":[]},{"type":"DRUG","name":"Placebo every 2 weeks","otherNames":[]},{"type":"DRUG","name":"Placebo every 4 weeks","otherNames":[]}],"arms":[{"label":"LY2127399 every 2 weeks","type":"EXPERIMENTAL"},{"label":"LY2127399 every 4 weeks","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this SLE study is to evaluate the efficacy, safety and tolerability of two different doses of LY2127399 administered in addition to standard of care therapy in participants with active SLE.","primaryOutcome":{"measure":"Percentage of Participants Achieving an SLE Responder Index Response at Week 52","timeFrame":"52 weeks","effectByArm":[{"arm":"LY2127399 Every 2 Weeks","deltaMin":38.5,"sd":null},{"arm":"LY2127399 Every 4 Weeks","deltaMin":34.8,"sd":null},{"arm":"Placebo","deltaMin":27.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":15},"locations":{"siteCount":185,"countries":["United States","Australia","Brazil","Canada","Ecuador","France","Hungary","India","Israel","Latvia","Malaysia","Mexico","New Zealand","Romania","Russia","Serbia","South Africa","Spain","Taiwan","Tunisia","United Kingdom"]},"refs":{"pmids":["38676311","35947992","33687069","31790472","29045736","27723281","27220348","26293163"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":46,"n":371},"commonTop":["Urinary tract infection","Upper respiratory tract infection","Headache","Nausea","Diarrhoea"]}}